Effective December 3, 2025, meconium drug screen testing for Southeast Michigan will transition from ARUP to Corewell Health Reference Laboratory West.
This change ensures consistent, high-quality testing across all Corewell Health regions and clinically standardizes the services we provide as a system.
What’s Changing:
Southeast Michigan specimens will now be tested at Corewell Health Reference Laboratory West
Collection and transport processes remain unchanged.
Purpose of Test:
Meconium drug screen testing detects and documents fetal drug exposure during approximately the last trimester of a full-term pregnancy
For more information, please refer to the Lab Test Directory: Meconium Drug Testing LAB479